Proactive Investors - Run By Investors For Investors

Avacta Plc 'making significant progress towards commercialising Affimer platform'

Capital Network analyst Riccardo Lowi discusses Avacta Group Plc (LON:AVCT) following the release of its preliminary results.

Lowi says over the last year or so, management's delivered significant progress in bringing their Affimer platform into the commercial stage, across both therapeutics and diagnostic applications.

View full AVCT profile View Profile

Avacta Group PLC Timeline

CN Research
April 09 2019

Related Videos

Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use